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Mechanistic target of rapamycin (mTOR) is a serine/threonine protein kinase that mediates 
phosphoinositide-3-kinase (PI3K)/AKT signalling. This pathway is involved in a plethora of cellular 
functions including protein and lipid synthesis, cell migration, cell proliferation and apoptosis. In this 
study, we proposed to delineate the role of mTORC1 in haemopoietic lineage commitment using 
knock out (KO) mouse and cell line models. Mx1-cre and Vav-cre expression systems were used to 
specifically target Raptorfl/fl (mTORC1), either in all tissues upon poly(I:C) inoculation, or specifically 
in haemopoietic stem cells, respectively. Assessment of the role of mTORC1 during the early stages 
of development in Vav-cre+Raptorfl/fl mice, revealed that these mice do not survive post birth due 
to aberrations in erythropoiesis resulting from an arrest in development at the megakaryocyte-
erythrocyte progenitor stage. Furthermore, Raptor-deficient mice exhibited a block in B cell lineage 
commitment. The essential role of Raptor (mTORC1) in erythrocyte and B lineage commitment was 
confirmed in adult Mx1-cre+Raptorfl/fl mice upon cre-recombinase induction. These studies were 
supported by results showing that the expression of key lineage commitment regulators, GATA1, 
GATA2 and PAX5 were dysregulated in the absence of mTORC1-mediated signals. The regulatory 
role of mTOR during erythropoiesis was confirmed in vitro by demonstrating a reduction of K562 cell 
differentiation towards RBCs in the presence of established mTOR inhibitors. While mTORC1 plays a 
fundamental role in promoting RBC development, we showed that mTORC2 has an opposing role, as 
Rictor-deficient progenitor cells exhibited an elevation in RBC colony formation ex vivo. Collectively, 
our data demonstrate a critical role played by mTORC1 in regulating the haemopoietic cell lineage 
commitment.
Recent studies of erythroid differentiation have revealed differences in the lineage potential of distinct cellular 
subsets between fetal and adult progenitor populations, with a higher proportion of megakaryocyte-erythroid 
progenitors arising from multipotent and oligopotent progenitor subsets during fetal haemopoiesis, while adult 
erythroid-committed cells are derived predominantly from unipotent progenitors1. These studies suggest that 
the erythroid cell lineage may be differentially regulated during ontogeny. Multipotent progenitor (MPP) cells 
give rise to lymphoid-primed multipotent progenitors (LMPPs) and oligopotent common myeloid progeni-
tors (CMPs). LMPPs have the capacity to differentiate towards common lymphoid progenitors (CLPs) mainly, 
with reduced megakaryocyte-erythroid progenitor (MEP) potential, while CMPs branch towards MEPs and 
granulocyte-macrophage progenitor (GMP) cells2. MEPs further commit to the erythroid lineage through for-
mation of burst-forming unit-erythroid (BFU-E) and then colony-forming unit-erythroid (CFU-E) cells, which 
then progress through erythroblast stages, reticulocyte maturation and terminal differentiation into red blood 
cells (RBCs)3.
Erythropoiesis is governed by the complex regulation of key transcription factors (TFs), enabling a balance 
between self-renewal and differentiation of erythrocyte progenitors and terminal erythroblasts. The zinc-finger 
TFs GATA1 and GATA2 play critical and non-redundant roles during erythroid maturation. GATA2 is expressed 
in HSCs and early progenitor populations regulating the expression of self-renewal genes, and genes responsible 
for initiating GATA1 expression. GATA1 plays a vital role in erythroid differentiation, sustaining its own expres-
sion and suppressing GATA2 expression, a process called GATA factor switching. GATA1-deficient (GATA1−/−) 
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murine embryos give rise to lymphoid cells and non-haemopoietic tissues, but not a mature erythroid population, 
resulting from a block at the pro-erythroblast stage due to increased apoptosis4. Ikaros also plays a role in fetal 
and adult erythropoiesis and erythroid lineage commitment, with Ikaros gene silencing leading to an irreversible 
switch to the myeloid lineage5. PU.1 TF is an established master regulator in haemopoiesis involved in primitive 
cell fate decisions. PU.1 expression levels determine myeloid and lymphoid cell fates: higher expression of PU.1 
leads to myeloid cell fate while a lower expression to a lymphoid fate6. The myeloid cell fate is not solely regulated 
by PU.1 expression, but also the inhibition of GATA17 and the expression of CEBPα8. PU.1 and GATA1 physically 
interact to regulate lineage fate where upregulation of GATA1 inhibits PU.1 transcription and promotes erythroid 
lineage differentiation9, while expression of PU.1 inhibits GATA1 expression promoting myeloid lineage fate10. 
GATA1 binds to the promoter region of erythroid-Krüppel-like factor (e-KLF/Klf1)11 which is vital for erythro-
poiesis, regulating MEP lineage fate decisions during erythrocyte development and globin switching from γ- to 
β-GLOBIN during erythrocyte maturation12. In humans, β-GLOBIN is expressed when erythropoiesis moves to 
the bone marrow (BM). Initially, the yolk-sac expresses ε-GLOBIN, followed by the expression of γ-GLOBIN in 
the fetal liver (FL) and spleen. Therefore, e-KLF mediated β-GLOBIN expression is vital for mature erythrocyte 
development13. While e-KLF plays a role in erythropoiesis, KLF2 is involved in endothelial growth, vascular 
remodeling and inflammation responses14, which is vital for embryonic development. Lower expression levels of 
PU.1 skew progenitors towards a lymphoid lineage enhancing E2A expression, a TF involved at the earliest stages 
of B cell development. Lack of E2A leads to a block in B cell development at the pre-proB and pro-B stages15. E2A 
drives the expression of early B cell factor 1 (EBF1), which together with E2A, regulate PAX5 and RAG genes 
responsible for B cell lineage commitment and V(D)J recombination to form the pre-B cell receptor complex on 
pre-B cells16.
The mTOR/AKT signaling pathway has been shown to play a vital role in haemopoietic lineage develop-
ment and maturation. The mTOR pathway is activated by a variety of growth factor receptors and nutrients 
including glucose, iron and amino acids. mTOR forms two different complexes – mTORC1 and mTORC2. 
mTORC1 is composed of 6 proteins and mTORC2 of 7 proteins. Of these, mTOR kinase is common, along with 
GβL, DEPTOR, and the TTI1/TEL2 complex. The subunits that make the respective complexes unique are 
RAPTOR (rapamycin TOR-sensitive) and PRAS40 for mTORC1 and RICTOR (rapamycin TOR-insensitive), 
mSIN1, and PROTOR1/2 for mTORC2. AKT lies upstream of mTORC1 and downstream of mTORC2 thus 
playing a crucial role in mTOR pathway regulation17. Downstream of mTORC1, S6 kinase 1 (S6K1) inhib-
its mTORC2 activity, thereby creating a negative feedback loop and another regulatory mechanism for this 
pathway18.
A critical role of mTORC1 has been identified in erythropoiesis whereby mTORC1 is regulated by dietary iron 
and Raptor ablation at the haemopoietic stem cell (HSC) stage leads to perinatal lethality19. Furthermore Raptor 
KO and overexpression leads to microcytic and macrocytic anaemia respectively19. However, discrepancies in 
the field remain, as there is research demonstrating that mTORC1 inhibition does not cause anaemia20 and that 
mTORC1 inhibition improves anaemia in a sickle cell disease model21. In this study, we address the role of Raptor 
(mTORC1) in normal haemopoietic lineage commitment both in fetal and adult developmental stages, using the 
cre-LoxP system to excise Raptor (mTORC1) in adult mice (Mx1-cre) and at the HSC stage (Vav-cre) in embryos, 
as well as the K562 cell line, to address the role of mTOR-mediated signals during RBC differentiation.
Results
mTORC1 plays a critical role in B cell and RBC lineage development in vivo. Genotyping analyses 
of Vav-cre+/− x Raptorwt/fl breedings revealed that the mice exhibiting the Vav-Raptor KO (Vav-cre−/+Raptorfl/
fl) did not reach weaning age (4 wk), while being present at normal ratios during gestation, suggesting that Vav-
cre−/+Raptorfl/fl mice died perinatally (Table 1). Analysis of embryos (E13–17) revealed a significant downreg-
ulation of Raptor expression in FL isolated from Vav-Raptor KO mice as expected, and the embryos were pale 
during gestation compared to Vav-cre−/−Raptorfl/fl (Vav-Raptor control) (Fig. 1A,B, & data not shown). Induction 
of Raptor excision with poly(I:C) in adult Mx1-Raptor cKO mice revealed a significant downregulation in Raptor 
expression in the BM and spleen (Fig. 1C) together with an increase in splenic weight and cellularity, and BM 
cellularity in Mx1-cre+Raptorfl/fl mice (Mx1-Raptor cKO) compared to Mx1-cre−Raptorfl/fl mice (Mx1-Raptor con-
trol) (Fig. 1D–G).
Analysis for the presence of selected haemopoietic lineages in these mouse models revealed a small but sig-
nificant decrease in the percentage of Ter119+ erythroid populations in Vav-Raptor KO FL at E15 compared 
to Vav-Raptor control (Fig. 2A & Suppl Fig. 1A). Additionally, there was a trend in decrease in the percent-
age of Ter119+ erythroid populations in the BM, coupled with a significant increase in percentage of Ter119+ 
Age
Medelian 
Ratio Cre−Raptorwt/fl
Cre− 
Raptorfl/fl
Cre+ 
Raptorwt/fl
Cre+ 
Raptorfl/fl
Chi2 
Value p Value
Weaning
Expected 6.5 6.5 6.5 6.5 14.92 **
Actual 13 9 4 0
E13
Expected 12.25 12.25 12.25 12.25 2.92 0.50
Actual 12 8 15 14
Table 1. Deletion of Raptor in the haemopoietic lineages leads to death prior to weaning. The expected 
mendelian ratios and actual genotyped ratios of Vav-cre+/− Raptorwt/fl mouse matings are shown at weaning 
(4 wk; n = 26) and at embryonic day 13 (E13; n = 49). Chi test values and statistical analyses are shown 
(**p ≤ 0.001). p value calculated by the Chi Test which determines p value based on degrees of freedom.
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population in the spleen likely due to increased extramedullary haemopoiesis in Mx1-Raptor cKO mice compared 
to Mx1-Raptor control (Fig. 2B & Suppl Fig. 1B). Flow cytometric analysis of B lineage cells revealed a significant 
downregulation in the percentage of CD19+ B lineage cells in E17 Vav-KO FL and Mx1-cKO BM, spleen and 
blood (Fig. 2C–E; Suppl. Fig. 1), coupled with a significant decrease in the number of CD19+ B lineage cells in the 
Mx1-cKO BM (Fig. 2F). These data suggest a vital role for mTORC1 in B cell development. Both the KO models 
showed a concomitant increase in the percentage of CD11b+Gr1− immature myeloid cells, together with a signif-
icant decrease in the percentage of CD11b+Gr1+ mature myeloid cells (Fig. 2G,H,J; Suppl. Fig. 1). These data were 
coupled with a significant increase in the number of CD11b+Gr1− myeloid cells in the Mx1-cKO BM (Fig. 2I), 
while the mature myeloid cell numbers were unaltered in the Mx1-cKO BM and spleen (Fig. 2K). These data sug-
gest that myeloid lineage maturation is deregulated in the absence of Raptor expression. As it is well established 
that mice can survive in the absence of white blood cell populations22, the absence of adult Vav-Raptor KO mice 
is likely due to the critical role of mTORC1 in erythropoiesis which results in the decrease in RBC populations 
and the pallor of the mice.
mTORC1 plays a critical role in B and RBC lineage commitment in vivo. To gain a deeper under-
standing of the stage at which Raptor-deficiency blocks lineage commitment/development we carried out flow 
cytometric analysis on the haemopoietic progenitor populations. Supporting the lack of CD19+ B cells, a signif-
icant reduction in the percentage of pre-proB and pro-B cells was noted in FL and BM isolated from Vav-Raptor 
KO and Mx1-Raptor cKO mice respectively, compared with control mice (Fig. 3A,B; Suppl. Fig. 2). This finding 
Figure 1. Vav-cre+Raptorfl/fl mice die perinatally in the absence of raptor expression. (A) Gene expression 
data showing expression of Raptor with cre expression in Vav-cre+Raptorfl/fl (Vav-Raptor KO) compared to 
Vav-cre−Raptorfl/fl (control) E15 FL (n = 6). (B) Picture showing the difference in pallor in E13 FL between 
Vav-cre−Raptorwt/fl and Vav-KO fetal mice; C. Gene expression of Raptor in the BM and spleen in Mx1-cre− and 
Mx1-cre+Raptorfl/fl mice (red, Mx1-Raptor cKO; n = 5); D. Picture showing splenomegaly in Mx1-Raptor cKO 
mice compared to Mx1-Raptor control; Graphs showing spleen weight (mg) (E), spleen cellularity (F) and BM 
cellularity (G) of Mx1-Raptor control (blue) and Mx1-Raptor cKO mice (n ≥ 4). All Mx1-cre mice were given 4 
doses of poly(I:C) and assessed 5 wk post inoculation. Data are expressed as mean ± SEM, t-test (unpaired) (p 
* ≤ 0.05; ** ≤ 0.001; *** ≤ 0.0001; **** ≤ 0.00001.
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was coupled with a significant elevation in the Lin−Sca-1+CD117hi (LSK) population, suggesting a block in B cell 
development prior to lineage commitment. Of note, no significant differences in LSK and progenitor B cell pop-
ulations were observed between VavCre+/−Raptorwt/wt and VavCre−Raptorfl/fl mice, indicating that the phenotypic 
changes were due to the excision of Raptor (Fig. 3A). Analysis of the proportion of myeloid progenitors in E15 
Figure 2. Mx1/Vav-cre+Raptorfl/fl mice exhibit a disruption in haemopoiesis in vivo. Graphs showing the 
percentage of haemopoietic lineage calculated from flow cytometry data gated as indicated in Supplemental 
Fig. 1. Average percentage of Ter119+ erythroid population in Vav-cre−Raptorwt/fl, Vav-Raptor control, and 
Vav-Raptor KO E15 FLs (n = 7) (A) and BM and spleen of Mx1-Raptor control and Mx1-Raptor cKO mice 
(n = 3) (B); Average percentage of CD19+ B cells in E15 (n = 6) (C) and E17 (n = 4) (D) FLs and BM, spleen and 
blood of Mx1-Raptor control and Mx1-Raptor cKO mice (n = 5) (E); Average number of CD19+ B cells in BM 
and spleen of Mx1-Raptor control and Mx1-Raptor cKO mice (n = 5) (F); Average percentage of CD11b+Gr1− 
(immature myeloid) and CD11b+Gr-1+ mature myeloid populations in Vav-control, and Vav-KO E15 FLs 
(n = 6) (G), and CD11b+Gr1− (immature myeloid) (H) and CD11b+Gr-1+ mature myeloid populations (J) 
in Mx1-Raptor control and Mx1-Raptor cKO BM and spleens (n = 5). Average number of CD11b+Gr1− (I) 
and CD11b+Gr-1+ myeloid populations (K) in Mx1-Raptor control and Mx1-Raptor cKO BM and spleens 
(n = 5). All Mx1-cre mice were given 4 doses of poly(I:C) and assessed 5 wk post inoculation. Light blue bars - 
cre−Raptorwt/fl; blue - cre−Raptorfl/fl; red bars - cre+Raptorwt/fl; maroon bars - cre+Raptorfl/fl as indicated. Data are 
expressed as mean ± SEM, one way ANOVA (p * ≤ 0.05; ** ≤ 0.001; *** ≤ 0.0001; **** ≤ 0.00001).
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FL isolated from Vav-Raptor KO mice revealed no significant changes in the Sca-1loCD117hi, CMP and GMP 
populations compared to the control mice (Fig. 3C; Suppl. Fig. 3A). An elevation in the percentage of MEPs in 
E13 and E15 FLs isolated from Vav-Raptor KO mice suggested a developmental arrest in erythropoiesis at the 
MEP stage in the absence of Raptor expression at the HSC stage in vivo (Fig. 3D). Interestingly, adult mice with 
an induced Raptor-deficiency exhibited a significant decrease in Sca-1loCD117hi population and MEP population 
suggesting a block in erythropoiesis prior to the MEP stage in Mx1-Raptor cKO BM (Fig. 3E). Additionally, a 
significant decrease in GMP population was noted, suggesting that differentiation of CMPs towards GMP and 
MEPs is deregulated in the BM in Mx1-Raptor cre cKO mice. The difference in progenitor populations between 
the FL and BM with Raptor-deficiency highlights the potential for mTORC1 to play similar but not identical roles 
in lineage maintenance at different stages of development and ontogeny.
In support of our phenotypic analyses showing a block in B cell and RBC development, analysis of key genes 
responsible for enabling differential lineage commitment revealed a significant downregulation in the expression 
of B cell specific TFs Ebf1 and Pax5 in FLs isolated from Vav-Raptor KO mice, while Cebpα levels were unaltered 
(Fig. 3F,G). Assessing erythroid lineage commitment factors, Pu.1, β-Globin and Gata1 levels were significantly 
Figure 3. Mx1 and Vav-cre+Raptorfl/fl mice exhibit a block in B and RBC lineage commitment at the LSK and 
MEP stage in vivo. Surface expression of Lin−Sca-1+CD117+ (LSK), pre-proB (CD117+B220+CD19−) and 
proB (CD117+CD19+B220+) populations in E15 Vav-Raptor KO FL compared to Vav-cre−Raptorwt/fl and Vav-
cre−/+Raptorwt/wt FL controls (n = 6) (A) and in BM of Mx1-Raptor control (blue) compared to Mx1-Raptor 
cKO (red) mice (n = 6) (B); (C) Graph showing surface expression of S1loc-Kithi (Sca-1loCD117hi), CMP, GMP 
populations in E15 FL in Vav-cre−Raptorwt/fl (light blue) and Vav-Raptor control (blue) and Vav-cre+Raptorwt/
fl (light red) and Vav-Raptor KO (dark red) (n = 6); (D) Surface expression of megakaryocyte erythrocyte 
progenitor (MEP) in E13 and E15 FL in Vav-KO mice compared to cre+Raptorwt/fl and Vav-control (E13 n ≥ 3; 
E15 n ≥ 6); (E) BM of Mx1-control or Mx1-cKO mice showing surface expression of S1loc-Kithi, CMP, GMP 
and MEP populations (n ≥ 5); Gene expression of E17 FL demonstrating the fold change in Pu.1, early B cell 
factor 1 (Ebf1), and Pax5 gene expression (F), along with fold changes in gene expression of E15 FL Cebpα, 
Gata1, Gata2, βGlobin (G), and Kruppel-like factor 1 and 2 (Klf1 and Klf2) (H) in CD45+ sorted Vav-Raptor 
KO FL compared to Vav-Raptor control FL cells (n ≥ 4). All Mx1-cre mice were given 4 doses of poly(I:C) and 
assessed 5 wk post inoculation. Data are expressed as mean ± SEM, one way ANOVA (p * ≤ 0.05; ** ≤ 0.001; 
*** ≤ 0.0001; **** ≤ 0.00001).
6Scientific RepoRtS |         (2019) 9:16917  | https://doi.org/10.1038/s41598-019-53141-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
downregulated in Vav-Raptor KO mice with trends in an increase in Gata2 levels. Additionally, there was a signif-
icant downregulation in the expression of Klf1 and Klf2, TFs which play a role in embryonic erythropoiesis and 
development (Fig. 3H), indicating an aberration in erythropoiesis with Raptor deficiency in Vav-KO FLs.
Inhibition of mTORC1 blocks RBC differentiation in vitro. To further assess the role of mTORC1 in 
RBC differentiation in vitro, we made use of the human BCR-ABL+ erythroleukaemia cell line K562, that differen-
tiates towards a RBC-like lineage when exposed to stress23–25. Stress was induced by replacing glucose in complete 
media with galactose (Gal-media)26. A significant increase in the percentage of CD71+GlyA+ cells, an elevation 
of the erythroid marker CD71 surface expression and a reduction in cellular granularity was observed (Fig. 4A,B, 
Suppl. Fig. 4A) in K562 cells cultured in Gal-media, coupled with a significant increase in gene expression of 
β-GLOBIN, GATA1 and GATA2 (Fig. 4C). Treatment of K562 cells with either rapamycin (allosteric mTORC1 
inhibitor) or AZD8055 (dual mTORC1/2 inhibitor) reduced erythroid differentiation in vitro, as indicated by a 
significant decrease in the generation of erythroid cells and a reduction in gene expression of erythroid markers, 
(Fig. 4B,C), indicating mTORC1 inhibition blocks RBC differentiation in vitro.
To assess erythroid colony formation capacity of HPCs in the absence of mTORC1 activity, HPCs were isolated 
from BM of Mx1-Raptor control or cKO mice and CFC assays were performed. Mx1-Raptor cKO mice lacked 
CFC activity, as indicated by the lack of colony-forming unit-erythroid (CFU-E), blast-forming unit-erythroid 
(BFU-E) or granulocyte-erythroid-megakaryocyte-macrophage (GEMM) colonies in the absence of Raptor 
expression, compared to cre− controls (Fig. 5A,B). Interestingly, myeloid progenitor CFC assays performed in 
Vav-cre− (Vav-Rictor control) and cre+Rictorfl/fl (Vav-Rictor KO) HPCs to assess the role of mTORC2 in early mye-
loid/erythroid colony formation demonstrated a significant increase in CFU-E colonies and a trend in increase 
in GEMM colonies in Vav-Rictor KO HPCs (Fig. 5C,D), suggesting a suppressive role of mTORC2 in erythro-
poiesis. Supporting these data, flow cytometric analysis of the CFCs generated showed a decrease in percentage 
of Ter119+ cells in Mx1-Raptor cKO HPCs, while an increase was noted in Vav-Rictor KO HPCs (Suppl. Fig. 5).
Discussion
Our data support previously published work demonstrating a critical role of mTORC1 during B cell and eryth-
roid development in two mouse models of Raptor-deletion in vivo, and further demonstrate the importance of 
mTORC1 function in in vitro RBC differentiation models: CFC assays and human cell line K562.
Figure 4. Role of mTORC1 in the differentiation of RBCs in a human cell model at the phenotype and gene 
transcription level in vitro. (A) Flow cytometry representative plot showing the levels of granularity (FSC-A 
vs. SSC-A) and in CD71+GlyA+ surface expression in K562 cells cultured in complete media or galactose-
containing media. (B) Average percentage of CD71+GlyA+ cells and MFI ratio of CD71+ expression in K562 
cells (n = 4) when glucose is replaced with galactose (golden bars) in K562 complete media (grey bars). (C) 
Gene expression of β-GLOBIN, GATA1 and GATA2 in K562 cells in complete media compared with cells with 
galactose treatment with or without mTOR inhibitors – rapamycin or AZD8055. Data (n = 4) are expressed as 
mean ± SEM, t-test (unpaired) (p * ≤ 0.05; ** ≤ 0.001; *** ≤ 0.0001; **** ≤ 0.00001).
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Examining the role of mTORC1 in normal erythropoiesis at the HSC stage, in both fetal and adult mice, 
revealed subtle differences at the two developmental stages. Raptor-deficient embryos were paler than 
Raptor-control mice, characteristic of mice with RBC deficiency as noted in EPO/EPO-R mice27. Knight et al., 
demonstrated high mTORC1 activity in proE cells (reticulocytes) characterised by elevated phosphorylation of 
the downstream target S6 thereby identifying a critical role for mTORC1 in RBC development. Additionally, they 
showed a link between iron availability and haemoglobin (Hb) synthesis in RBC development with mTORC1 
signalling, as RBCs have decreased mTORC1 signalling during iron deficiency (ID) in vitro and in vivo19. We 
observed a significant decrease in Ter119+ erythrocytes, with an arrest at the MEP stage shown by a significant 
increase in the MEP population at E15, together with an increase in Sca-1lo CD117hi cells in the FL of Vav-Raptor 
KO. This is consistent with published data demonstrating Vav-Raptor KO FL exhibit microcytic anaemia with 
Figure 5. Mx1-Raptor cKO mice exhibit a functional block in RBC development. (A) Colony formation cell 
assays (CFCs) which optimise for the growth of erythroid cells were carried out on Mx1-Raptor control (control: 
left) and Mx1-Raptor cKO (cKO: right) BM enriched for haemopoietic stem/progenitor cells (HSPCs). All 
Mx1-cre mice were given 4 doses of poly(I:C) assessed 5 wk post last inoculation. (B) Colony counts of different 
erythroid colonies: colony-forming unit-erythroid (CFU-E), burst-forming unit-erythroid (BFU-E) and CFU 
of granulocyte-erythroid-macrophage-megakaryocyte (CFU-GEMM) in cre+Raptorfl/fl KO models and in 
cre− controls (n ≥ 6). (C) Colony formation cell assays (CFCs) which optimise for the growth of haematopoietic 
progenitor colonies were carried out on Vav-Rictor control (control: left) and Vav-Rictor KO (KO: right) BM 
enriched for HPCs. (D) Colony counts of different haematopoietic colonies: CFU-E, BFU-E and CFU-GEMM 
in cre+Rictorfl/fl KO models and in cre− controls (n ≥ 6). Data are expressed as mean ± SEM, unpaired t-test 
(p * ≤ 0.05; ** ≤ 0.001; *** ≤ 0.0001; **** ≤ 0.00001). (E) Schematic summary of the role of mTORC1 in B 
and erythrocyte development. Haemopoietic stem cells (HSCs), which have self-renewal capacity, give rise 
to multipotent progenitors (MPPs) which can develop towards common myeloid progenitors (CMPs), or 
lymphoid primed multipotent progenitors (LMPPs), which give rise to common lymphoid progenitors(CLPs) 
or certain myeloid cell lineages. CMPs further give rise to megakaryocyte-erythroid progenitors (MEPs) which 
develop into erythrocytes along with other lineages. CLPs give rise to lymphoid lineages including B cell lineage. 
Yellow lighting arrows represent stages of haemopoietic development where the role of mTORC1 is vital for 
further development.
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decreased Hb, exhibiting increased proE cells and decreased EryC populations. Conversely, constitutive activa-
tion of mTORC1 (Vav-TSC1 KO) leads to macrocytic anaemia with larger reticulocytes and RBCs with elevated 
Hb levels. Despite increased Hb levels in RBCs, there was a decrease in RBC output in the BM (decreased EryB), 
leading to stress erythropoiesis in the spleen (elevated EryA population) with an overall decrease in Hb19. A 
steady decline in progenitor populations occurred over time, with no significant difference in MEP populations 
between the controls and Vav-Raptor KO FL at E17 (data not shown), diminishing any significant differences 
observed in FL at E13/E15. This is likely due to a transition in haemopoiesis from the FL to the BM, which 
begins before birth at E16.528. The block in development of the erythroid lineage was supported by a significant 
downregulation in Gata1, β-Globin, Klf1 and Klf2 expression with Raptor-deficiency at the HSC stage, suggesting 
mTORC1-mediated signalling may aid in the regulation of GATA switching to enable erythropoiesis.
In contrast, induced Raptor-deficiency in adult mice (Mx1-Raptor cKO) is not lethal, and these mice displayed 
a significant decrease in Sca-1loCD117hi and MEP populations in the BM. This may be due to the lineage potential 
of progenitors differing between fetal and adult mice, as FL HSCs possess a higher proliferative and metabolic 
capacity (increased oxidative phosphorylation) than BM-derived HSCs which could affect Sca-1loCD117hi and 
MEP primitive populations29. Nevertheless, there is a trend in decrease in Ter119+ erythroid population in the 
BM of adult mice with Raptor-deficiency, as noted in the Vav-cre model, suggesting a disruption in erythropoiesis 
in the BM. Indeed, Guo et al., demonstrated that Mx1-Raptor cKO mice have reduced RBCs and Hb in the BM 
due to increased apoptosis of RBCs. Additionally, erythrocyte development was blocked at the proE stage30 con-
firming our results that mTORC1 blocks RBC development. Mx1-Raptor cKO mice exhibited splenomegaly, with 
the spleen showing a significant increase in Ter119+ population, which could suggest a possible compensatory 
mechanism leading to the promotion of erythropoiesis due to a lack of erythrocytes, suggesting extramedullary 
haemopoiesis in the spleen, as has been shown previously31. Alternatively, as the spleen is known to be a main site 
for erythrophagocytosis, it is possible that the function of these erythrocytes is compromised and are accumu-
lated in the spleen for phagocytosis30. We observe splenomegaly and an increase in red pulp. As the red pulp is 
one of the major sites of erythrocyte destruction, it is possible that an accumulation of erythrocytes in the spleen 
indicates erythrocyte depletion32. The observed differences between the models may be due to the mechanism of 
Raptor-excision. While both models result in the deletion of Raptor in all haemopoietic lineages, the Mx1-Raptor 
cKO requires inoculation with poly(I:C), through induction of type 1 interferons, which may disrupt haemopoi-
etic cell survival. Published studies indicate that the impact of poly(I:C) treatment on haemopoietic cells is tran-
sient, lasting for up to 48 hr33. Here, phenotypic analyses were carried out 5 wk after the last poly(I:C) inoculation, 
by which time the key poly(I:C) induced effect should be Raptor-excision. While this timeline may enable the 
outgrowth of undeleted alleles in Mx1-Raptor cKO mice, the optimisation of poly(I:C) induced Raptor-excision 
leading up to this study reduced the likelihood of this occurring in the timeframe of these experiments, and 
Raptor expression was consistently downregulated up to 8 wk post-poly(I:C) inoculation.
Using established mTOR inhibitors to block RBC differentiation in the K562 cell line provided support for 
the results presented from our mouse models, indicating that erythroid development is dependent on mTORC1 
activity. Interestingly, a recent report shows that K562 cells express a distinct mTOR-containing complex, 
mTORC3 (mTOR associated with ETV7) that lacks other mTORC1/2 containing proteins, and is associated with 
rapamycin-resistance when upregulated in human cancer cells34. Our finding that K562 differentiation is inhib-
ited by rapamycin treatment suggests that mTORC3 does not play a major role in this process. Supporting this, 
Ohyashiki et al. have previously shown that iron regulates mTORC1 signalling in RBCs as iron chelators greatly 
reduced mTORC1 signalling in K562 cells35. Overexpression of eIF4E and sustained mTORC1 expression in 
erythroid progenitor cell line I/11 also improves differentiation36,37. An additional role of mTORC1 in initiation of 
translation at early stages in RBC development has been reported, demonstrating the regulation of mitochondrial 
biogenesis from HSPCs to proerythroblasts by mTORC138. This study shows a unique requirement for mTORC1 
in RBC development. These data, together with our findings suggest that mTORC1, iron metabolism and eryth-
ropoiesis have an inter-dependent regulatory link.
Assessment of erythroid colony formation capacity revealed that Raptor-deficient BM lacked colony forma-
tion capacity. Consistent with this, Mx1-Raptor cKO cells have previously been shown to lack the ability to form 
CFU-E and BFU-E colonies30. Indeed, shRNA targeting S6K1 in murine BM cells significantly decreased CFU-E 
and BFU-E colony formation capacity demonstrating the importance of mTORC1-S6K axis is mediating eryth-
ropoiesis39. ER-Raptor cKO LSK cells also lack colony formation capacity which is rescued by the retroviral trans-
duction of Raptor suggesting the importance of mTORC1 in haemopoiesis40. Our assessment of Rictor-deficient 
BM colony formation capacity revealed that Vav-Rictor KO BM formed a significantly higher number of eryth-
roid colonies than their controls. This suggests a possible feedback system for erythroid regulation wherein 
mTORC1 drives erythroid formation, whereas mTORC2 suppresses erythropoiesis. Our study compared the 
Mx1-Raptor cKO and Vav-Rictor KO models. Vav-mediated KO models generate a constitutive KO, which can 
result in signalling pathway adaptation41. Indeed, crosstalk between ERK-MAPK and mTOR signalling pathways 
has recently been demonstrated, with ERK activity regulating mTORC1 activation to limit the promotion of 
HSC cycling in favour of quiescence. HSCs derived from MEK1-cKO mice exhibit exhaustion due to increased 
mTORC1-mediated ROS production resulting in increased mitochondrial damage42. While each model has a 
different timing for gene deletion, the cells placed in CFC assays were removed from Mx1-Raptor mice 5 wk after 
inoculation with poly(I:C) in vivo, thus inducing optimal Raptor excision.
Of note, publications also suggest that mTORC1 negatively regulates erythropoiesis, via heme-regulated eIF2α 
kinase (HRI) and activation transcription factor 4 (ATF4), in a mouse model of ID. HRI is activated in response 
to heme deficiency, thereby stimulating ATF4 to regulate Hb levels via the translation of stress response genes. In 
mutant mice that lack phosphorylated eIF2α (eIF2αP) in the RBC lineage (eAA)43, mTORC1 activity is elevated 
in erythroid precursors. This study demonstrated that eIF2αP and ATF4 of HRI-integrated stress response are 
required in ID to repress mTORC1 signalling and mitigate ineffective erythropoiesis. As such, pharmacological 
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inhibition of mTORC1 significantly improved RBC production and differentiation, and increased Hb levels in 
the blood43. Furthermore, constitutive activation of mTORC1 in haemopoietic lineages exhibited macrocytic 
hyperchromic anaemia with splenomegaly and ineffective erythropoiesis19, similar to that seen in HRI−/− 
mice. However, although ATF4 is required to inhibit mTORC1 signalling, ATF4−/− mice develop microcytic 
hypochromic anaemia, unlike HRI−/− mice43. These studies suggest that mTORC1 activity plays an inhibitory 
role in erythropoiesis during ID anaemia. Furthermore, Foxo3−/− mice (model with similar genotypic profile to 
β-thalassemia), exhibit increased phosphorylation of mTOR targets including AKT, S6, 4EBP1, suggesting aber-
rant mTOR signalling in diseased conditions. Treatment of Foxo3−/− mice with rapamycin increased RBC counts 
and Hb levels, with increased cell cycling in immature erythrocytes compared to untreated mice39. Therefore, in 
contrast to normal erythropoiesis, where mTORC1 plays a fundamental role in RBC generation, diseased condi-
tions alter mTORC1 signalling to disrupt erythropoiesis, which is overcome by mTORC1 inhibitors.
The early block in B cell lineage commitment and development in the FL and BM of both Raptor-deficient 
models, mirrored that described previously in Mx1-Raptor cKO mice31. The observed increase in LSK popula-
tions, which normally give rise to pre-proB cells, in both BM and E15 FL suggests a block at the LSK stage during 
B cell development with Raptor-deficiency at the fetal and in adult stages of development. These findings were 
supported by the observed downregulation in Ebf1 and Pax5, TFs essential for B cell lineage commitment. A 
similar trend has been observed in the BM of mTOR-cKO mice, and the spleen of Mx1-Raptor cKO mice, with 
the majority of LSK cells in S phase suggesting increased cell cycling due to perturbations in mTORC1 signal-
ling29,30. Iwata et al., demonstrate a block in B cell development at the pre-B cell stage within Mb1-Raptor cKO 
adult mice, which is not rescued by the introduction of an anti-apoptotic BclXL transgene suggesting that this 
block, caused by the lack of mTORC1, is independent of BCLXL44. Our model, which excises Raptor at the HSC 
stage, demonstrates a requirement for mTORC1 signalling for B cell lineage commitment. In ER-Raptor cKO BM 
there is an increase in LSK cells together with a decrease in phosphorylation of 4EBP1 and S6 and decrease in 
mature B cells40 indicating that the role of mTORC1 in B lymphopoiesis is not model specific. Indeed, Zeng et al. 
highlight the importance of mTORC1 specifically in B cell development and proliferation, but not survival, in an 
IL7R-mTORC1-Myc dependent and STAT5-independent manner, as the loss of mTORC1 leads to a block at the 
proB cell stage in CD2-mTOR and CD2-Raptor cKO models45. Furthermore, Keating et al. demonstrated a critical 
role for mTORC1 in B cell class switching and anti-viral responses, with Rosa26-Raptor KO mice having reduced 
germinal centre formation in response to influenza infection, a finding that was replicated with rapamycin treat-
ment. Interestingly, rapamycin treatment prevented B cell class-switching, yielding antibodies that mediated het-
erosubtypic protection, by targeting more conserved regions of hemagglutinin, a surface protein expressed on 
viruses46. H&E staining of spleens isolated from Mx1-Raptor cKO mice lack a defined architecture and displayed 
a reduction in marginal zones and germinal centres (data not shown).
In agreement with previously published data, similar roles of mTORC1 in myeloid lineage development were 
observed in both fetal and adult mice with a significant increase in CD11b+Gr1− populations and a concomitant 
decrease in CD11b+Gr1+ populations in both Vav-Raptor KO FL and Mx1-Raptor cKO BM30,31. This result has 
been recapitulated in ER-cre model suggesting that the role of mTORC1 in myeloid development is not model 
specific40. We observed a decrease in GMP population leading to a decrease in mature myeloid population 
with Raptor-deficiency in Mx1-Raptor cKO mice. Indeed, a decrease in CMPs has previously been reported in 
Mx1-Raptor cKO mice30 supporting the decrease in mature myeloid lineage with Raptor-deficiency. However, the 
increase in CD11b+ population in both models also suggests that even though there is a block in early myeloid 
populations, it does not disrupt the ability of the progenitors to develop into immature myeloid cells. ER-Raptor 
cKO mice displayed an increase in GMP and MEP populations with a block in CD11b+Gr1+ mature myeloid 
populations with no changes in pS6, alluding to the phenotypic differences between KO models. The lack of 
change in pS6 expression in myeloid cells (with a significant decrease in pS6 in B cells) suggests a differential 
regulation of mTORC1 activity in different haemopoietic lineages40. Nonetheless, mTORC1 plays a role in the 
maturation of myeloid cells in both adult and fetal models. While previous studies support a cell autonomous 
effect of Raptor-deletion in the development of haemopoietic lineages30,31, mixed BM chimeras should be per-
formed to confirm our results, as myeloid lineage expansion has the potential to inhibit erythroid and lymphoid 
lineages47,48. In addition, deletion of Raptor in HSCs has been shown to affect osteoclast generation, which in turn 
would impact the BM microenvironment and subsequent haemopoiesis49.
Taken together, we performed analyses in two different mTORC1 KO mouse models at different stages of 
development in vivo and two distinct RBC differentiation assays in vitro to tease out the role of mTORC1 in hae-
mopoietic lineage development. We confirm the fundamental role of mTORC1 in haemopoiesis, during RBC and 
B cell lineage commitment both in fetal and adult mice (Fig. 5E).
Materials and Methods
Mice. Mice expressing floxed Raptor (Raptorfl/fl) or Rictor (Rictorfl/fl) constructs were obtained from Prof. 
Michael N. Hall (University of Basel, Switzerland)50. Prof. Tessa L. Holyoake (University of Glasgow, UK) pro-
vided transgenic mice expressing Mx1-cre and Vav-cre, which were bred and maintained at the Beatson Research 
Unit (Glasgow, UK). All experimental protocols were approved by the local AWERB committee and national 
home office, and all methods were carried out in accordance with standard animal housing conditions under local 
and home office regulations. Mx1-cre−/+ or Vav-cre−/+ transgenic mice were crossed with Raptorfl/fl or Rictorfl/fl  
to obtain the desired KO models. The Mx1 promoter was activated in Mx1-cre−/+-Raptorfl/fl or -Rictorfl/fl mice 
by inoculating the mice with 4 doses of 10 mg/kg polyionosinic:polycytidylic acid (poly(I:C); TLR3 agonist) 
once every 2 days to induce a conditional KO (cKO). The mice were assessed 5 wk after the last inoculation. No 
significant differences were observed in organ cellularity, and B/myeloid lineage percentage and number when 
B6.SJL wild type mice and Mx1-Cre−Raptorfl/fl mice were compared after treatment with poly(I:C); Supplemental 
Fig. 6). The Vav promoter is active at E13 in HSCs, thereby inducing a haemopoietic-restricted KO. Haemopoietic 
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lineage cells in a single cell suspension were isolated from BM, spleen and blood of transgenic mice, and filtered 
through a 70 µm nylon mesh (Fisher Scientific, Leicestershire, UK). The cells collected from the BM and spleen 
were enriched for haemopoietic lineage cells by density centrifugation using Lympholyte-Mammal (Cedarlane, 
Canada), centrifuging the cell suspension for 20 min at 625 g at RT. Thereafter the cells were washed in PBS, cen-
trifuged at 500 g for 10 min at RT and counted.
Flow cytometry. Samples derived from the organs were prepared for flow cytometry as described previ-
ously51. All antibodies were purchased from BD Biosciences (Oxford, UK), except Gr-1 (Clone RB6-8C5; eBio-
sciences) and Ter119 (Clone TER-119; BioLegend). K562 cells with/without treatment were harvested and 2 × 105 
cells were stained with GlyA (Clone GAR2) and CD71 (Clone AC102) from Miltenyi Biotec. All samples were sus-
pended in 100 µl PBS and acquired using the FACSDiva software package (BD Biosciences) on the FACSCantoII 
flow cytometer. The resultant data were analysed using FlowJo software (Tree Star Inc., OR).
qRT-PCR. RNA was extracted from fresh cells by following the RNAeasy Qiagen Kit protocol. cDNA was then 
made from the RNA using standard protocols provided by Invitrogen. Alternatively, CD45+ cells were sorted 
into the PCR tubes (300 cells/tube) containing the one-step PCR master mix of 5 µl (Cells direct 2x reaction 
(2.8 µl), 0.2x Primer mix (1.4 µl), RNAase out (0.056 µl), Superscript III RT/Platinum Taq Mix (0.112 µl), TE 
Buffer (0.672 µl) (part of SuperScript™ III Platinum™ One-Step qRT-PCR Kit, Invitrogen)). Samples were run on 
a PCR with the following conditions: 50 °C for 15 min, 95 °C for 2 min followed by 20 cycles of 95 °C for 15 sec and 
65 °C for 4 min. The samples were then held at 4 °C. After the completion of the PCR, the samples were diluted 
10x with TE buffer (45 µl). qPCR was carried out by using 300 nM of forward and reverse primer for each gene. 
All reactions were performed in technical triplicates and at least three biological replicates using the 7900HT Fast 
Real-Time PCR system (Applied Biosystems, Warrington, UK), programmed to complete 40 cycles as follows: 
50 °C for 20 min, 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 sec, and 60 °C for 1 min. The primers used 
are listed in Supplementary Table 1. The q/RT-PCR follows the MIQE guidelines52.
Erythroid differentiation of K562 cells. For normal cell growth, K562 cells were cultured in RPMI-
1640 supplemented with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin and 2 mM L-Glutamine (complete 
media). To induce erythroid differentiation, K562 cells were cultured in RPMI-1640 (no glucose) supplemented 
with 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin, 2 mM L-Glutamine and 11 mM Galactose (Gal-media). 
For erythroid differentiation, K562 cells (2 × 105) were cultured in either complete media or Gal-media for up to 7 
days and then analysed by flow cytometry or qPCR. For drug treatments, cells were treated with 10 nM rapamycin 
(allosteric mTORC1 inhibitor) or 100 nM AZD8055 (competitive dual mTORC1/2 inhibitor) or vehicle control 
(DMSO) as indicated.
Colony forming cell (CFC) assay. Bones from transgenic mice were crushed and enriched for haemopoi-
etic lineages as described above. Haemopoietic progenitor cells (HPCs) were isolated using the MACS mouse 
CD117 MicroBeads according to the manufacturer’s protocol (Miltenyi Biotec, Surrey, UK). Up to 2 × 104 cells 
were then plated in MethoCultTM M3334 erythroid colony promoting methylcellulose or MethoCultTM GF 
M3434, in 6 cm dishes as per the manufacturer’s protocol (Stemcell Technologies, Grenoble, France). The dishes 
were monitored and colonies were counted.
Statistics. The Chi Test was used to assess whether there were statistical differences between the different 
genotypes generated from crossing Vav-cre−/+Raptorfl/fl mice. Chi Test calculates deviations by chance if the 
expected ratios are known. Medelian ratios were the expected ratios, which were compared to the genotypes 
observed at weaning stage of mice. The statistical significance, if any, is calculated using the Chi Test taking into 
account the degrees of freedom53. Statistical analyses were carried out between the data sets using GraphPad 
Prism 6 Software (San Diego, California, USA). Statistical analyses carried out were unpaired t tests, or for data 
with multiple comparisons one way ANOVA, where p ≤ 0.05 is considered significant. * ≤ 0.05; ** ≤ 0.001; 
*** ≤ 0.0001; **** ≤ 0.00001.
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